BioBoss

Follow BioBoss
Share on
Copy link to clipboard

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders, CEOs, and executives of today's most innovative companies. Listen each month as branding veteran John Simboli poses the questions "What drives you? How do you make change? Why should I care?" to a new…

John Simboli


    • May 24, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 33m AVG DURATION
    • 86 EPISODES


    Search for episodes from BioBoss with a specific topic:

    Latest episodes from BioBoss

    Derek Adams: CEO of Stellular Bio

    Play Episode Listen Later May 24, 2025 42:34


    Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.

    Geoffrey Dow: CEO of 60 Degrees Pharmaceuticals

    Play Episode Listen Later Apr 29, 2025 32:43


    Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.

    Jorge Santos da Silva: Co-Founder and CEO of MoonLake Immunotherapeutics

    Play Episode Listen Later Mar 29, 2025 40:28


    Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people living with serious inflammatory diseases. 

    Vlad Vitoc - Founder and CEO of MAIA Biotechnology

    Play Episode Listen Later Feb 27, 2025 35:45 Transcription Available


    Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer.

    What Leads the Leaders? Insights from BioBoss Season 1

    Play Episode Listen Later Jan 25, 2025 7:21


    “What leads a leader?”As you listen to clips from BioBoss podcasts, you may hear remarkably consistent ideas about leadership, as shared by BioBoss guests, who reflect on their younger years and how those experiences shaped their desire, and ability to lead.  

    Welcome to Season 7 of BioBoss

    Play Episode Listen Later Dec 5, 2024 1:17


    BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025

    Sam Clark: Founder and CEO of Terran Biosciences

    Play Episode Listen Later Oct 31, 2024 40:50 Transcription Available


    Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neurological and psychiatric diseases. 

    Iain Kilty: CEO of Sitryx

    Play Episode Listen Later Sep 28, 2024 40:50 Transcription Available


    Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease

    Steve Uden: Co-Founder and CEO of Rallybio

    Play Episode Listen Later Jul 29, 2024 31:32 Transcription Available


    Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly  change the odds for patients living with rare diseases.

    Karine Rossignol: Co-Founder and CEO of Smart Immune

    Play Episode Listen Later May 21, 2024 35:56


    Karine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the immune system against cancer and infection.

    Erik Buntinx: Founder and CEO of ANeuroTech

    Play Episode Listen Later Apr 20, 2024 49:17 Transcription Available


    Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression

    Helen Torley: CEO of Halozyme Therapeutics

    Play Episode Listen Later Mar 25, 2024 39:09 Transcription Available


    Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.

    James Graham: CEO of Recce Pharmaceuticals

    Play Episode Listen Later Feb 24, 2024 21:06 Transcription Available


    James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.

    Mike Gaffney: CEO of Cellphire Therapeutics

    Play Episode Listen Later Jan 27, 2024 39:17 Transcription Available


    Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need.

    #66 - David Baram: founder and CEO of EmendoBio

    Play Episode Play 43 sec Highlight Listen Later Dec 16, 2023 35:41 Transcription Available


    David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

    Welcome to Season 6 of BioBoss

    Play Episode Listen Later Dec 15, 2023 0:44 Transcription Available


    BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024

    #65 - Anat Binur: co-founder & CEO of Ukko

    Play Episode Play 33 sec Highlight Listen Later Nov 7, 2023 35:42


    Anat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.

    #64 - Markku Jalkanen: founder & CEO, Faron Pharmaceuticals

    Play Episode Play 38 sec Highlight Listen Later Oct 6, 2023 27:58 Transcription Available


    Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.

    #63 - Lisa Deschamps: CEO of AviadoBio

    Play Episode Listen Later Sep 11, 2023 46:22


    Lisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating and life-threatening neurodegenerative disorders.

    #62 - Leonard Mazur: Founder & CEO, Citius Pharma

    Play Episode Play 41 sec Highlight Listen Later Aug 12, 2023 32:35


    Leonard Mazur, founder and CEO of Citius Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Citius is working to unlock the potential of first-in-class critical care therapeutics, with a pipeline of anti-infectives in oncology, adjunct cancer care and stem cell therapy.

    #60 - Dario Neri: co-founder & CEO, Philogen

    Play Episode Play 38 sec Highlight Listen Later Jul 1, 2023 39:13


    Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and chronic inflammation.

    #60 - Naseem Amin: CEO of Orphalan

    Play Episode Play 41 sec Highlight Listen Later May 27, 2023 43:47 Transcription Available


    Naseem Amin,  CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.

    #59 - Hartmut Ehrlich: CEO of Abivax

    Play Episode Play 45 sec Highlight Listen Later Apr 22, 2023 50:11 Transcription Available


    Hartmut Ehrlich,  CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body's natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.

    #58 - Ivo Timmermans: co-founder & CEO, Pleco Therapeutics

    Play Episode Play 33 sec Highlight Listen Later Apr 1, 2023 41:32 Transcription Available


    Ivo Timmermans, co-founder and  CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.

    #57 - Philipp Spycher: Co-founder & CEO, Araris Biotech

    Play Episode Play 39 sec Highlight Listen Later Mar 4, 2023 39:22 Transcription Available


    Philipp Spycher, co-founder and  CEO of Araris Biotech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Araris is working to develop a linker technology for antibody-drug conjugates that enables attachment of any payload to ‘off the shelf' antibodies without the need of prior antibody engineering.

    #56 - Patrick Arensdorf: Founder & CEO, Exai Bio

    Play Episode Play 41 sec Highlight Listen Later Feb 4, 2023 39:01 Transcription Available


    Pat Arensdorf, founder and  CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer biology from a simple blood draw.

    #55 - Josh Geballe: Managing Director of Yale Ventures

    Play Episode Play 45 sec Highlight Listen Later Jan 1, 2023 34:27 Transcription Available


    Josh Geballe, Managing Director of Yale Ventures, shares his thoughts with BioBoss host John Simboli about leadership and community building in biopharma. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal of helping to develop innovations that impact the world's greatest challenges.

    Welcome to Season 5 of BioBoss

    Play Episode Listen Later Dec 31, 2022 0:59


    BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 ,3 and 4 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in  BioBoss season 5.John is delighted to open BioBoss season 5 with his conversation with Josh Geballe, Managing Director of Yale Ventures, who shares his thoughts about leadership, innovation, entrepreneurship and community building in biopharma and biotech. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal of helping to develop innovations that impact the world's greatest challenges.

    #54 - Luca Benatti: CEO, EryDel

    Play Episode Play 38 sec Highlight Listen Later Dec 3, 2022 41:31


    Luca Benatti,  CEO of EryDel, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how EryDel is working to develop specialized therapies for the treatment of rare diseases by using the patient's own blood.

    #53 - Elisabet de los Pinos: Founder/CEO, Aura Biosciences

    Play Episode Play 38 sec Highlight Listen Later Oct 29, 2022 35:05 Transcription Available


    Elisabet de los Pinos, founder and CEO of Aura Biosciences, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Aura is working to envision new ways to treat cancer.

    #52 - Paul Radspinner: Founder & CEO, Flugen

    Play Episode Play 44 sec Highlight Listen Later Oct 8, 2022 46:00 Transcription Available


    Paul Radspinner, founder and CEO of Flugen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Flugen is working to develop a more effective vaccine in the fight against influenza and respiratory disease.

    #51: Jesús Martin-Garcia - CEO of GeNeuro

    Play Episode Play 44 sec Highlight Listen Later Sep 19, 2022 42:01 Transcription Available


    Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.

    #50 - Cliff Stocks: Founder and CEO, OncoResponse

    Play Episode Play 36 sec Highlight Listen Later Aug 17, 2022 34:25 Transcription Available


    Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff's insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

    #49 - Brian Finrow: Co-founder & CEO, Lumen Bioscience

    Play Episode Play 37 sec Highlight Listen Later Jul 16, 2022 41:08 Transcription Available


    Brian Finrow, Co-founder and CEO of Lumen Bioscience, speaks with BioBoss host and biopharma branding veteran John Simboli. Hear Brian's thoughts about leadership and how Lumen Biosciences is working to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. 

    #48 - Alex Blyth: Founder & CEO, LifT BioSciences

    Play Episode Play 38 sec Highlight Listen Later Jun 18, 2022 36:36 Transcription Available


    #47 - Andrew Hall: CEO of IMV Inc.

    Play Episode Play 39 sec Highlight Listen Later May 21, 2022 30:23 Transcription Available


    #46 - Kevin Lee: CEO of Bicycle Biotherapeutics

    Play Episode Play 43 sec Highlight Listen Later Apr 18, 2022 39:47 Transcription Available


    Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics. 

    #45 - Reenie McCarthy: CEO of Stealth BioTherapeutics

    Play Episode Play 41 sec Highlight Listen Later Mar 26, 2022 27:05 Transcription Available


    BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.

    #44 - Yochi Slonim: Founder & CEO, Anima Biotech

    Play Episode Play 50 sec Highlight Listen Later Feb 5, 2022 40:43 Transcription Available


    BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.

    #43 - Clive Richardson: CEO of Akari Therapeutics

    Play Episode Play 38 sec Highlight Listen Later Jan 8, 2022 32:36 Transcription Available


    BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics  is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene  pathways

    Welcome to Season 4 of BioBoss

    Play Episode Listen Later Dec 28, 2021 1:20 Transcription Available


    BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in  BioBoss season 4.

    #42 - Stefan König: CEO of George Medicines

    Play Episode Play 39 sec Highlight Listen Later Dec 4, 2021 38:06 Transcription Available


    BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan's thoughts about leadership in biopharma and how George Medicines is working to extend and improve the lives of people suffering from the world's leading causes of death and disability—including hypertension, cardiovascular disease and type 2 diabetes

    #41 - Derek Maetzold: CEO of Castle Biosciences

    Play Episode Play 39 sec Highlight Listen Later Oct 29, 2021 38:12 Transcription Available


    Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence techniques to improve patient outcomes.

    #40 - Bob Cobuzzi - CEO of Diffusion Pharmaceuticals

    Play Episode Play 36 sec Highlight Listen Later Oct 2, 2021 34:22 Transcription Available


    Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhance the body's ability to deliver oxygen to the areas where it is needed most.

    #38 - Panna Sharma - CEO of Lantern Therapeutics

    Play Episode Play 38 sec Highlight Listen Later Sep 12, 2021 38:38 Transcription Available


    Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial intelligence, genomics and machine learning to advance precision oncology therapies.

    #37 - Nandan Padukone: CEO of IM Therapeutics

    Play Episode Play 43 sec Highlight Listen Later Jul 31, 2021 44:36 Transcription Available


    Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.

    #36 - Matthew Gline: CEO of Roivant Sciences

    Play Episode Play 35 sec Highlight Listen Later Jul 10, 2021 39:20 Transcription Available


    #35 - Koen De Witte: Managing Director, ReMYND

    Play Episode Play 34 sec Highlight Listen Later May 30, 2021 31:19 Transcription Available


    Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer's, diabetes and other diseases caused by cellular dysfunction. 

    #34 - Lanny Sun: co-founder, Silicon Therapeutics

    Play Episode Play 43 sec Highlight Listen Later May 1, 2021 36:43 Transcription Available


    Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now part of Roivant Drug Discovery, is advancing its chip-to-clinic, computational quantum physics-based approach to pioneer a new path for drug design of  medicines to improve the lives of patients

    #34 - Joan Perelló: Co-Founder and CEO of Sanifit

    Play Episode Play 39 sec Highlight Listen Later Apr 3, 2021 36:43 Transcription Available


    Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.

    #33 - Saiid Zarrabian: CEO of Kintara Therapeutics

    Play Episode Play 44 sec Highlight Listen Later Mar 13, 2021 27:15 Transcription Available


    Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare unmet medical needs.

    Claim BioBoss

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel